Lippincott Medicine

Lippincott Medicine Healthcare professionals, researchers, educators, and students around the world rely on our solutions. Our content is written and reviewed by experts.

Lippincott is a leading international medical publisher of professional health information for practitioners, faculty, residents, students, and healthcare institutions. It’s authoritative and based on the best available evidence. It’s curated and aggregated to be both premier and comprehensive. And it’s delivered through powerful tools and technology for fast access to the exact information you ne

ed—whether you’re learning or teaching in the classroom, treating a patient, or conducting research. You can rely on Lippincott for the tools, resources, and accurate, accessible healthcare information—from the start of your education to your first day in practice, and throughout your career. Before posting on this page or leaving any comments, please review the terms below:

A posting on this page constitutes acceptance of these terms. Wolters Kluwer reserves the right to remove and/or block anyone who posts inappropriate material as determined by the organization. Wolters Kluwer reserves the right to remove any comments that are inappropriate or offensive, including comments that:

are false or without merit, defame, abuse, harass, stalk, threaten or violate the legal rights of others, include racism, hatred, slander, threats, obscenity, violence, vulgarity, spam or advertisements, have personal information about another person or that violate a person's privacy interests, including copyrighted material belonging to another person, contain links to inappropriate or offensive websites, contain solicitations of commerce, are not topically related.

MASLD affects nearly 30% of people worldwide, with significant implications for cardiometabolic health.A study in JAAPA ...
05/22/2026

MASLD affects nearly 30% of people worldwide, with significant implications for cardiometabolic health.

A study in JAAPA outlines how primary care PAs can use noninvasive screening tools to better assess fibrosis risk and identify patients who may benefit from emerging therapies like resmetirom.

Read the study: https://ow.ly/Pwy750Z1Imo

The trusted resource in pediatric cardiology is now available as an enhanced eBook with multimedia. Moss and Adams’ Hear...
05/21/2026

The trusted resource in pediatric cardiology is now available as an enhanced eBook with multimedia. Moss and Adams’ Heart Disease in Infants, Children, and Adolescents provides authoritative, up-to-date clinical guidance for diagnosing and managing congenital and acquired heart disease across the pediatric population. Explore the complete resource: https://ow.ly/E4rr50Z17TQ

Timing shapes uterine immunity before implantation. This study shows uterine epithelial estrogen receptor α regulates th...
05/19/2026

Timing shapes uterine immunity before implantation. This study shows uterine epithelial estrogen receptor α regulates the preimplantation immune environment over time, with interleukin-1β signalling playing a central role. https://ow.ly/2m0q50Z1gOO

Research from Dermatologic Surgery explores AI's role in diagnosing melanoma and carcinoma, and what it means for equita...
05/18/2026

Research from Dermatologic Surgery explores AI's role in diagnosing melanoma and carcinoma, and what it means for equitable care. Read now: https://ow.ly/T4mV50YZ2J8

Real-world data from China’s IsaFiRsT study shows isatuximab + pomalidomide + dexamethasone (Isa-Pd) achieves high & dee...
05/16/2026

Real-world data from China’s IsaFiRsT study shows isatuximab + pomalidomide + dexamethasone (Isa-Pd) achieves high & deep responses in heavily pretreated relapsed/refractory multiple myeloma (RRMM): ORR 82.6%, ≥CR 43.5%. Responses are rapid (median TTR 1.2 months). Superior efficacy vs. historical controls with manageable safety, consistent with global trials. https://ow.ly/Frpg50YZ2BH


Chinese Medical Journal

A streamlined, evidence-based guide for treating substance use disorders, ASAM Essentials of Addiction Medicine draws fr...
05/14/2026

A streamlined, evidence-based guide for treating substance use disorders, ASAM Essentials of Addiction Medicine draws from the ASAM Principles of Addiction Medicine, 7th Edition, to present core clinical content in focused chapters. Updated by more than 300 experts, it includes key points and review tools to support clinical practice and certification exam preparation. Learn more: https://ow.ly/xZYz50YTxI6

05/12/2026
Get quick, reliable answers for rounds and exams. Pocket Medicine offers easily accessible bulleted lists, tables, and a...
05/12/2026

Get quick, reliable answers for rounds and exams. Pocket Medicine offers easily accessible bulleted lists, tables, and algorithms to help you make accurate diagnoses and build state-of-the-art treatment plans. Learn more: https://ow.ly/M8K850YUZEO

This Skin Cancer Awareness Month, explore the evidence-based research informing diagnosis and surgical decision-making f...
05/11/2026

This Skin Cancer Awareness Month, explore the evidence-based research informing diagnosis and surgical decision-making for dermatologic surgeons. Explore today: https://ow.ly/H5fE50YW8IP

New study in the Chinese Medical Journal: Family history (FH) of cancer and early cancer onset in China. This multicente...
05/10/2026

New study in the Chinese Medical Journal: Family history (FH) of cancer and early cancer onset in China. This multicenter study analyzed 41,072 patients with lung, stomach, esophageal, or colorectal cancer across 12 provinces. Patients with first‑degree cancer FH were diagnosed 1.19 years younger, with the largest difference in colorectal cancer (−2.25 years). Lead‑time bias overestimated the FH effect by 3.4%–15.4%. Family history is strongly associated with earlier cancer diagnosis. Earlier cancer screening is strongly suggested for people with a family history of cancer. https://ow.ly/GMg950YVxYN

Lippincott® Clinical Context brings essential digital learning resources together in one easy‑to‑use platform, supportin...
05/08/2026

Lippincott® Clinical Context brings essential digital learning resources together in one easy‑to‑use platform, supporting learners from the first day of medical school through clerkship, residency, board preparation, and clinical practice.

Discover how Lippincott Clinical Context can support your program: https://ow.ly/nmJx50YRS3P

Address

Philadelphia, PA
19103

Alerts

Be the first to know and let us send you an email when Lippincott Medicine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Lippincott Medicine:

Featured

Share